Michele Senni
#162,927
Most Influential Person Now
Researcher
Michele Senni's AcademicInfluence.com Rankings
Michele Sennicomputer-science Degrees
Computer Science
#9522
World Rank
#9996
Historical Rank
Computational Linguistics
#2313
World Rank
#2336
Historical Rank
Machine Learning
#4190
World Rank
#4239
Historical Rank
Artificial Intelligence
#4536
World Rank
#4598
Historical Rank
Download Badge
Computer Science
Michele Senni's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Michele Senni Influential?
(Suggest an Edit or Addition)Michele Senni's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. (2020) (1835)
- Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. (1998) (1093)
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) (1081)
- Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. (2019) (1066)
- Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era (2020) (673)
- Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure (2015) (554)
- Congestive heart failure in the community: trends in incidence and survival in a 10-year period. (1999) (418)
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. (2014) (318)
- Developing therapies for heart failure with preserved ejection fraction: current state and future directions. (2014) (317)
- Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. (2015) (285)
- Heart failure with preserved systolic function. A different natural history? (2001) (283)
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure (2019) (250)
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. (2018) (241)
- Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial (2012) (206)
- Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. (2015) (199)
- Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). (2002) (196)
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens (2016) (191)
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study (2019) (191)
- Mode of Death in Heart Failure With Preserved Ejection Fraction. (2017) (178)
- Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry (2018) (164)
- Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction (2017) (161)
- Use of echocardiography in the management of congestive heart failure in the community. (1999) (156)
- Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. (2002) (152)
- Multicenter Prospective Observational Study on Acute and Chronic Heart Failure: One-Year Follow-up Results of IN-HF (Italian Network on Heart Failure) Outcome Registry (2013) (148)
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome (2017) (144)
- Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta‐analysis of observational studies (2017) (143)
- Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF. (2015) (124)
- Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. (2015) (124)
- Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. (2020) (121)
- Acute heart failure patient profiles, management and in‐hospital outcome: results of the Italian Registry on Heart Failure Outcome (2012) (119)
- Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial (2018) (110)
- Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides (2017) (109)
- Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score. (2013) (106)
- Geographic variations in the PARADIGM-HF heart failure trial (2016) (106)
- Prevalence and prognostic impact of non‐cardiac co‐morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community‐based study (2018) (104)
- In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. (2014) (96)
- Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study (2020) (95)
- A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure (2014) (91)
- Left ventricular systolic and diastolic function after pericardiectomy in patients with constrictive pericarditis: Doppler echocardiographic findings and correlation with clinical status. (1999) (90)
- Management of heart failure patients with COVID‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology (2020) (89)
- A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy (2012) (87)
- Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure: Insights From the IMAGE-HF Study. (2016) (86)
- Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use (2015) (84)
- Multicenter Prospective Observational Study on Acute and Chronic Heart FailureClinical Perspective (2013) (80)
- Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy (2015) (78)
- Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study (2021) (78)
- Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. (2014) (78)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
- Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA‐FR and COAPT trials? (2019) (74)
- Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial (2020) (70)
- End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractility. (2005) (69)
- Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review (2016) (69)
- Fibrinogen is an independent marker for thoracic aortic atherosclerosis. (1998) (64)
- Haemodynamic characteristics of COVID‐19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization (2020) (63)
- Transcatheter treatment for tricuspid valve disease. (2021) (61)
- Developing New Treatments for Heart Failure: Focus on the Heart (2016) (59)
- Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. (2021) (57)
- Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). (2014) (57)
- Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial (2021) (56)
- A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure. (2006) (54)
- COVID-19 experience in Bergamo, Italy (2020) (51)
- Congestive heart failure in elderly patients. (1997) (51)
- Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week. (2020) (51)
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study (2019) (51)
- Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction (2020) (51)
- Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure. (2002) (50)
- Impact of systolic blood pressure on the safety and tolerability of initiating and up‐titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study (2018) (50)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
- Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study (2021) (46)
- Congestive Heart Failure in the Community (1998) (46)
- Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years (2019) (45)
- Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction (2019) (45)
- Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction (2016) (45)
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe (2020) (45)
- Rationale and design of TRANSITION: a randomized trial of pre‐discharge vs. post‐discharge initiation of sacubitril/valsartan (2017) (45)
- Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis (2022) (44)
- Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery (2014) (44)
- Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. (2015) (42)
- Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999. (2005) (42)
- COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. (2020) (42)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
- Prognostic scores in heart failure - Critical appraisal and practical use. (2015) (42)
- COVID-19 in Heart Transplant Recipients (2020) (42)
- Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). (2015) (39)
- Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease) (2017) (39)
- Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction (2021) (38)
- Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure (2017) (36)
- Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM‐HF (2017) (34)
- Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) (2013) (33)
- Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. (2020) (32)
- Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study). (2012) (32)
- Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure. (2018) (31)
- The 30‐day metric in acute heart failure revisited: data from IN‐HF Outcome, an Italian nationwide cardiology registry (2015) (31)
- Reduction of Haemorrhagic Complications during Mechanically Assisted Circulation with the Use of a Multi-System Anticoagulation Protocol (1995) (30)
- Lessons learned in acute heart failure (2018) (29)
- CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. (2019) (29)
- Pre‐discharge and early post‐discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial (2018) (29)
- Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study. (2018) (28)
- At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy. (2020) (27)
- Restrictive mitral valve annuloplasty versus mitral valve replacement for functional ischemic mitral regurgitation: an exercise echocardiographic study. (2014) (27)
- Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3‐left ventricular hypertrophy (Beta3‐LVH) (2018) (27)
- Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study (2020) (25)
- Treatment with inotropes and related prognosis in acute heart failure: contemporary data from the Italian Network on Heart Failure (IN-HF) Outcome registry. (2014) (25)
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
- Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities (2020) (24)
- COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology (2021) (24)
- Repair of giant hernias using more prosthesis (2001) (24)
- Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives. (2019) (24)
- Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study (2021) (23)
- Prevention of left ventricular remodelling after acute myocardial infarction: an update. (2010) (23)
- Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: the relevance of the left ventricular equator as a prognostic factor. (2006) (23)
- The risk of coronary artery disease after heart transplantation is increased in patients receiving low‐dose cyclosporine, regardless of blood cyclosporine levels (1997) (23)
- Mitral valve repair and transesophageal echocardiographic findings in a high-risk subgroup of patients with active, acute infective endocarditis. (2001) (22)
- Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients (2021) (22)
- Clinical features, and in-hospital and 1-year mortalities of patients with acute heart failure and severe renal dysfunction. Data from the Italian Registry IN-HF Outcome. (2013) (21)
- Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. (2018) (21)
- Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review. (2021) (21)
- The prognostic value of serial troponin measurements in patients admitted for COVID‐19 (2021) (21)
- [Epidemiology and risk factors for heart failure in the elderly]. (2004) (21)
- Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use (2021) (21)
- P886Initiation of sacubitril/valsartan in hospitalized patients with heart failure with reduced ejection fraction after hemodynamic stabilization: primary results of the TRANSITION study (2018) (21)
- Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis (2021) (20)
- Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery (2015) (20)
- Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial. (2021) (19)
- Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease (2017) (19)
- Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction (2021) (19)
- Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double‐blind, placebo‐controlled trial (2019) (19)
- Aortic valve disease with severe ventricular dysfunction: stentless valve for better recovery. (2002) (19)
- Sacubitril/valsartan (LCZ696) for the treatment of heart failure (2016) (19)
- Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart (2015) (19)
- Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction. (2016) (19)
- Monitoring of biomarkers in heart failure (2019) (18)
- Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction? (2019) (18)
- Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients (2016) (18)
- Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 (2021) (18)
- How patients with heart failure are managed in Italy (2001) (18)
- Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation. (2015) (18)
- NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. (2020) (17)
- Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. (2021) (17)
- Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial (2016) (16)
- Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation. (1995) (15)
- Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients. (2016) (15)
- Pelvic prolapse: static and dynamic MRI (2007) (15)
- Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricular assist device implant: A machine learning approach (2019) (14)
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
- Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction (2019) (14)
- Clinical Outcomes, Pharmacologic Treatment and Quality of Life of Patients with Stable Coronary Artery Diseases Managed by Cardiologists: 1-Year Results of the START Study. (2019) (14)
- Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective. (2016) (14)
- N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure (2018) (14)
- Addressing the Heterogeneity of Heart Failure in Future Randomized Trials (2017) (13)
- Successful treatment of subacute constrictive pericarditis with interleukin-1β receptor antagonist (anakinra). (2015) (13)
- Images in cardiovascular medicine. Bacterial pericarditis due to Providencia stuartii: an atypical case of relapsing pericarditis. (2010) (13)
- Novel approaches to the post-myocardial infarction/heart failure neural remodeling (2014) (13)
- High-Sensitive Cardiac Troponin for Prediction of Clinical Heart Failure: Are We Ready for Prime Time? (2017) (12)
- An unexpected recovery of patients with pulmonary arterial hypertension and SARS-CoV-2 pneumonia: a case series (2020) (12)
- A multidisciplinary consensus document on follow‐up strategies for patients treated with percutaneous coronary intervention (2015) (12)
- Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high‐risk populations? Insights from the DAVID‐Berg study (2018) (12)
- Exercise Hemodynamic and Functional Capacity After Mitral Valve Replacement in Patients With Ischemic Mitral Regurgitation: A Comparison of Mechanical Versus Biological Prostheses (2018) (12)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
- Troponin I as a specific marker for heart damage after heart transplantation in a patient with becker type muscular dystrophy. (1997) (12)
- Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. (2018) (12)
- Impact of the Coronavirus Disease-19 Outbreak on Physical Activity of Patients With Implantable Cardioverter Defibrillators (2020) (12)
- Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: an Italian consensus statement. (2014) (11)
- QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance (2019) (11)
- Autologous blood reinfusion during iatrogenic acute hemorrhagic cardiac tamponade: Safety and feasibility in a cohort of 30 patients (2018) (11)
- Angiotensin–neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure (2022) (11)
- Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial (2019) (11)
- Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs. (2017) (10)
- Left main stem patch plasty and aortic root homograft in Takayasu's disease. (2004) (10)
- Usefulness and clinical relevance of left ventricular global longitudinal systolic strain in patients with heart failure with preserved ejection fraction (2019) (10)
- Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction. (2017) (10)
- Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists (2015) (10)
- Implantation of an elastic ring at equator of the left ventricle influences cardiac mechanics in experimental acute ventricular dysfunction. (2007) (10)
- Low Incidence of Gastrointestinal Bleeding and Pump Thrombosis in Patients Receiving the INCOR LVAD System in the Long-term Follow-up (2015) (10)
- Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) (2022) (10)
- Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle? (2017) (10)
- Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context (2017) (9)
- Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence? (2020) (9)
- Pediatric heart transplantation without chronic maintenance steroids. (1993) (8)
- Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial). (2014) (8)
- Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing (2018) (8)
- Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes. (2021) (8)
- Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction (2022) (8)
- Sacubitril/valsartan: from a large clinical trial to clinical practice (2018) (8)
- CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study. (2011) (8)
- QRS fragmentation as a possible electrocardiographic diagnostic marker in patients with acute myocarditis: preliminary histopathological validation (2020) (8)
- Natriuretic peptides and the Framingham risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study. (2013) (7)
- Toward the development of a fully elastic mitral ring: preliminary, acute, in vivo evaluation of physiomechanical behavior. (2009) (7)
- Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects. (2020) (7)
- Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial (2022) (7)
- Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition. (2017) (7)
- Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials (2020) (7)
- Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial. (2020) (7)
- Multiplane transoesophageal echocardiographic detection of thoracic aortic plaque is a marker for coronary artery disease in women. (1997) (7)
- Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan (2021) (7)
- Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments (2012) (6)
- [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study]. (2014) (6)
- Sacubitril/Valsartan Initiated in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction after Hemodynamic Stabilization: Primary Results of the TRANSITION Study (2018) (6)
- The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction (2021) (6)
- Transvenous pacing in pediatric patients with bipolar lumenless lead: Ten-year clinical experience. (2018) (6)
- Ranolazine in Heart Failure With Preserved Left Ventricular Ejection Fraction and Microvascular Dysfunction: Case Report and Literature Review (2013) (6)
- Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. (2022) (5)
- [Sacubitril/valsartan, a new and effective treatment for heart failure with reduced ejection fraction]. (2017) (5)
- Cardiovascular Risk Factors and Complications in Patients Infected with COVID-19: A Systematic Review (2020) (5)
- [Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment]. (2009) (5)
- Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19 (2021) (5)
- Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin (2022) (5)
- CArdiac Resynchronization In combination with BEta blocker treatment in advanced chronic Heart Failure (CARIBE-HF): the results of the CARIBE-HF study (2011) (5)
- Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic (2021) (5)
- Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients. (1994) (4)
- Effect of Respiratory Impairment on the Outcomes of Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Coronavirus Disease-2019 (COVID-19). (2021) (4)
- Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
- Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF (2021) (4)
- Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model. (2021) (4)
- Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study. (2017) (4)
- Heart failure with preserved ejection fraction in Asia: the far side of the moon? (2018) (4)
- Early and intermediate term results of Carpentier's repair for Ebstein's anomaly. (1996) (4)
- Association of chronic kidney disease with abnormal cardiac structure and function in a HFpEF population : the PARAMOUNT study (2013) (4)
- Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients (2021) (4)
- Defining differences in community and trial CHF patients (1999) (4)
- Global Longitudinal Strain in master athletes and in hypertensive patients with the same degree of septal thickness (2017) (4)
- CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. (2020) (4)
- Reasons why patients suffering from chronic heart failure at very high risk for death survive. (2014) (4)
- Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction (2020) (4)
- Cardiogenic shock: How to overcome a clinical dilemma. Unmet needs in Emergency medicine. (2015) (4)
- Risk stratification in heart failure with mild reduced ejection fraction (2020) (4)
- OLD AND NEW EQUATIONS FOR MAXIMAL HEART RATE PREDICTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ON BETA-BLOCKERS TREATMENT. RESULTS FROM THE MECKI SCORE DATASET. (2022) (4)
- The Titan can help titin: from micro to macro myocardial elasticity (2006) (4)
- Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum (2022) (4)
- [ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure]. (2018) (3)
- The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure. (2014) (3)
- Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial (2022) (3)
- Remote Monitoring of Respiratory Pattern in an ICD Patient With COVID-19 Pneumonia (2021) (3)
- Epidemiologic and clinical profiles of bacterial myocarditis. Report of two cases and data from a pooled analysis (2020) (3)
- Abstract 15567: Short-Term Effect on Cardiac Biomarkers of Initiation of Sacubitril/Valsartan in Hospitalized Patients With Heart Failure and Reduced Ejection Fraction: Results of the Transition Study (2018) (3)
- Right and left ventricular structures and functions in acute HFpEF: comparing the hypertensive pulmonary edema and worsening heart failure phenotypes (2022) (3)
- Patient with valvular disease: evolving care patterns (2020) (3)
- The “Early Treatment” Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique (2021) (3)
- P6531Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF (2018) (3)
- Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology. (2022) (3)
- Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects. (2021) (3)
- [Heterotropic heart transplantation in young patients with elevated pulmonary vascular resistance]. (1999) (3)
- Challenges in remote monitoring of cardiac implantable electronic devices in 2021. (2021) (3)
- Monday, 27 August 2012 (2012) (3)
- One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity (2022) (3)
- [Heart rate and outcome in patients with acute and chronic heart failure]. (2016) (3)
- CHF trends: Comparing incidence and survival in 1981 and 1991 (1999) (3)
- MitraClip Treatment of Secondary Mitral Regurgitation in Heart Failure with Reduced Ejection Fraction: Lessons and Implications from Trials and Registries (2020) (3)
- Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study (2022) (2)
- Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial. (2021) (2)
- [Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives]. (2021) (2)
- Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations (2018) (2)
- Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”? (2016) (2)
- [Round ligament pathology: a report of two cases]. (2008) (2)
- Constrictive pericarditis: a common pathophysiology for different macroscopic anatomies. (2019) (2)
- Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial (2020) (2)
- Reasons why patients suffering from chronic heart failure at very low risk for mortality die. (2016) (2)
- [Update on tricuspid regurgitation]. (2014) (2)
- Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients (2020) (2)
- Clinical correlates of autonomic response during tilting test in hypertrophic cardiomyopathy (2017) (2)
- Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart (2020) (2)
- Echocardiographic Outflow Pump Ramp Test in Centrifugal-Flow Left Ventricular Assist Device (2017) (2)
- The right-side of the circulation in not secondary HFpEF: an elephant in the room? (2021) (2)
- Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19. (2021) (2)
- An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug (2021) (2)
- Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study (2022) (2)
- Acute necrotizing eosinophilic myocarditis presenting with cardiogenic shock after mRNA booster dose for COVID-19: Case report and review of literature (2022) (2)
- An Intriguing Case Report of Functional Mitral Regurgitation Treated With MitraClip (2015) (2)
- Cavotricuspid Isthmus Ablation and Subcutaneous Monitoring Device Implantation in a 2‐Year‐Old Baby with 2 SCN5A Mutations, Sinus Node Dysfunction, Atrial Flutter Recurrences, and Drug Induced Long‐QT Syndrome: A Tricky Case of Pediatric Overlap Syndrome? (2015) (2)
- Pick your threshold: a comparison among different methods of anaerobic threshold evaluation in heart failure prognostic assessment. (2022) (2)
- Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure. (2021) (2)
- Risk stratifying asymptomatic left ventricular systolic dysfunction in the community: beyond left ventricular ejection fraction. (2019) (2)
- [Continuity of care in patients with cardiac failure after acute event]. (2010) (2)
- Is 3D Echo With Ramp Test Indicated in Detecting Blood Flow Obstructions in HeartWare LVAD? (2016) (1)
- Medical treatment of end-stage heart failure. (1996) (1)
- Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy (2016) (1)
- Comparison of the Baseline Demographics of the LCZ696 PARADIGM-HF and TITRATION Studies (2015) (1)
- Hemodynamic arterial changes in heart failure: a proposed new paradigm of "Heart and Vessels Failure (HVF)". (2021) (1)
- Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction (2021) (1)
- Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base. (2022) (1)
- A 57-year-old man with rapidly progressive pulmonary hypertension. (2021) (1)
- Under-utilization of echocardiography in the management of congestive heart failure in the community has adverse effects on morbidity and mortality (1997) (1)
- Ventricular tachycardia originating from the crux of the heart treated with ablation within the cardiac venous system in a 12-year-old patient (2020) (1)
- Abstract 12886: In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial (2016) (1)
- Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study (2019) (1)
- Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysis. (2022) (1)
- An unusual case of cardiac aspergillosis. (2019) (1)
- 554 Machine learning for prediction of in-hospital mortality in COVID-19 patients: results from an Italian multicentre study (2021) (1)
- Can we improve the accuracy of electrocardiographic algorithms for accessory pathway location in children? (2021) (1)
- Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved (2022) (1)
- [Heart failure with preserved ejection fraction: an update on diagnosis and treatment]. (2020) (1)
- Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy (2022) (1)
- External closed-circuit cooling system for management of patients after device implantation: A feasibility study. (2017) (1)
- [Diagnosis and treatment of anemia in heart failure patients]. (2011) (1)
- Constrictive pericarditis: a common physiopathology for different macroscopic anatomies. (2019) (1)
- Reply to: "Effusive-constrictive pericarditis successfully treated with anakinra" G. Lazaros et al. Interleukin-1β receptor antagonist and pericardial constriction. (2015) (1)
- Elective replacement of a 4‐year‐old leadless pacemaker: New approach for end‐of‐life management (2021) (1)
- The myosin activator: is another step forward in heart failure therapy? (2021) (1)
- Reply to: ‘The hyperdynamic circulatory profile of patients with COVID‐19‐related acute vascular distress syndrome’ (2021) (1)
- The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? (2021) (1)
- Medical treatment of eng-stage heart failure (1996) (1)
- Experience of a pediatric electrophysiology clinic during the COVID‐19 pandemic (2022) (1)
- Barore fl ex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction (2015) (1)
- 1410Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study (2019) (1)
- Searching for Diagnostic Biomarkers of HFpEF: Methodological Issues. (2020) (1)
- Association between sleep disordered breathing, neurocognitive impairment and diastolic function in acute heart failure patients: an insight after the vulnerable phase of the hospitalization (2020) (1)
- [Is it time to organize a "new " campaign against congestive heart failure?]. (2003) (1)
- Corrigendum to ‘Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart’ [Eur J Heart Fail] 2015 August;17(8): 760–763. doi:10.1002/ejhf.315 (2015) (1)
- Renin profiling predicts neurohormonal response to sacubitril/valsartan (2020) (1)
- Practical Patient Care Considerations with Use of Vericiguat After Worsening Heart Failure Events. (2022) (1)
- The Pilot European Survey of Atrial Fibrillation: how to look at heart failure through a keyhole (2015) (1)
- [A novel standard protocol of long-term follow-up shared with general practitioners after percutaneous coronary intervention: appropriateness and economic impact]. (2015) (0)
- Sodium nitroprusside for advanced heart failure. A metanalysis of literature data. (2022) (0)
- Incidental cardiac aspergillomas in an immunocompromised woman (2019) (0)
- Abstract 15545: Incremental Prognostic Value of Echocardiographic Markers of Left Ventricular Remodeling and Diastolic Function in the Surgical Treatment for Ischemic Heart Failure Trial (2014) (0)
- P5661Influence of midwall fractional shortening on incident heart failure and death in asymptomatic subjects at high risk of events. Insights from the DAVID-Berg study (2018) (0)
- Abstract 15083: Exercise Left Ventricular Ejection Fraction Predicts Long-term Brain Natriuretic Peptide Levels in Patients Undergoing Surgery for Severe Secondary Ischemic Mitral Regurgitation (2020) (0)
- [Functional mitral regurgitation in heart failure: an unmet clinical need?]. (2012) (0)
- Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome (2022) (0)
- Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test (2021) (0)
- [Remarks on the guideline recommendations for cardioverter-defibrillator implantation for primary prevention of sudden cardiac Death in patients with severe ventricular dysfunction. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO)/Italian Society of Cardiology (SIC)/It (2013) (0)
- [Grey zones on new oral anticoagulants in atrial fibrillation. Expert opinion]. (2020) (0)
- [Gaps in evidence in recent cardiovascular guidelines: uncertainties in chronic coronary syndrome]. (2023) (0)
- 712 Value of 3D echocardiography systolic dyssynchrony index vs the Cardiovascular Medicine ‐ HF Index on the outcome of cardiac resynchronization therapy (2008) (0)
- Sacubitril/valsartan in real-life European patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis (2020) (0)
- LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure (2022) (0)
- Concise Review for Primary-Care Physicians Congestive Heart Failure in Elderly Patients (2011) (0)
- Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 (2016) (0)
- Is pulmonary artery wedge pressure a reliable surrogate of left ventricular end-diastolic pressure during exercise for diagnosing HFpEF in patients with unexplained dyspnea? (2022) (0)
- Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction. (2023) (0)
- Hemodynamic arterial changes in heart failure. a proposed new paradigm of heart and vessels failure. The Copernican revolution (2021) (0)
- [Appropriateness criteria for the treatment of atrial fibrillation with dronedarone: practical issues. An Italian cardiologists' expert opinion]. (2013) (0)
- 760 Bring-up beta-blockers implementation program in out-patient with heart failure. A national educational project (2005) (0)
- Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus (2022) (0)
- Tailored approach to trans-catheter palliation of critically reduced pulmonary blood supply. Data on long term follow up (2020) (0)
- [Grey zones on dual antiplatelet therapy. Expert opinion]. (2020) (0)
- Prognostic scores: one fits all? (2017) (0)
- [Analysis of the mechanical behavior of the right ventricle. Preliminary study]. (1972) (0)
- Right ventricular involvement in Hypertrophic Cardiomyopathy: role of CMR (2018) (0)
- P231 PULMONARY ARTERY WEDGE PRESSURE VS LEFT VENTRICULAR END–DIASTOLIC PRESSURE DURING EXERCISE IN PATIENTS WITH UNEXPLAINED DYSPNEA (2022) (0)
- Pulmonary Artery Wedge Pressure and Left Ventricular End-Diastolic pressure during exercise in patients with dyspnea (2023) (0)
- Progn Scores Review Ferrero Int J Cardiol 2015 (2015) (0)
- Abstract 18551: Predictors of Heart Failure and Death in a High Risk Diabetic Population: The DAVID-Berg Study (2014) (0)
- 1102 ARRYTHMOGENIC CARDIOMYOPATHY: LESSONS FROM A LARGE FAMILY (2022) (0)
- 012MITRAL VALVE ANNULOPLASTY VERSUS MITRAL VALVE REPLACEMENT FOR ISCHAEMIC MITRAL REGURGITATION: HAEMODYNAMIC AND FUNCTIONAL CAPACITY COMPARISON (2013) (0)
- Abstract 18200: Mitral Valve Annuloplasty Versus Mitral Valve Replacement for Ischemic Mitral Regurgitation: An Exercise Echocardiographic Study (2012) (0)
- Pericarditis : An Atypical Case of Relapsing (2011) (0)
- [Grey zones on diabetes in cardiovascular disease. Expert opinion]. (2020) (0)
- Searching for diagnostic biomarkers of heart failure with preserved ejection fraction: methodological issues (2020) (0)
- [The PARAGON-HF trial: missed opportunity or first personalized therapy?] (2020) (0)
- SAFETY AND EFFICACY OF ELECTIVE ELECTRIC CARDIOVERSION IN ATRIAL FIBRILLATION WITHOUT THE USE OF TRANSESOPHAGEAL ECHOCARDIOGRAM THE ECARTE STUDY (2020) (0)
- 39 The non‐cardiological complications during heart failure hospitalizations: prevalence and impact on length of stay (2008) (0)
- [Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?] (2023) (0)
- Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population). (2022) (0)
- Abstract 19125: Athletes With Repolarization Abnormalities During Exercise Stress Test Have a Lower Global Longitudinal Strain Compared to Hypertensive Patients With the Same Degree of Septal Thickness (2014) (0)
- Hemodynamic comparison of restrictive mitral valve annuloplasty and mitral valve replacement for ischemic mitral regurgitation (2013) (0)
- Poster session 2 (2011) (0)
- [Tailored follow-up for chronic heart failure patients: time for discussion]. (2010) (0)
- OP-EUPA210147 1603..1611 (2021) (0)
- [Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials]. (2022) (0)
- Azygos Vein ICD Lead Implantation Lowers Defibrillation Threshold in a Patient with Hypertrophic Cardiomyopathy (2021) (0)
- TCT-798 The 3C-HF as a new predictor of outcomes after MitraClip (2012) (0)
- [Grey zones on valvular heart disease: interventional cardiology versus cardiac surgery. Expert opinion]. (2020) (0)
- P296 HIDDEN PERICARDIAL CONSTRICTION IN A PATIENT WITH CHRONIC PERICARDIAL EFFUSION AND “UNEXPLAINED” DYSPNEA (2022) (0)
- [Present and future options for the surgical treatment of patients with advanced heart failure]. (2009) (0)
- P5678Real world eligibility and prognostic relevance for sacubitril/valsartan in unselected heart failure outpatients: data from an Italian registry (IN-HF outcome) (2018) (0)
- 4301Diastolic dysfunction is an independent predictor of adverse events in patients with systolic dysfunction. Insights from the MADIT-CRT trial (2019) (0)
- Red cell distribution width (RDW) is correlated to time of oxygen desaturation < 90% and length of sleep apneas in patients with sleep disorder breathing (SDB) and acute heart failure with preserved ejection fraction (HFpEF) (2023) (0)
- Diastolic Ventricular Interaction in a Heart Transplant Patient With Severe Tricuspid Regurgitation. (2022) (0)
- [Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients]. (2010) (0)
- Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible (2022) (0)
- 603 Temporal trends in survival and hospital admissions in patients with heart failure and preserved left ventricular function (2006) (0)
- 661 TWO CARDIOMYOPATHIES IN ONE HEART: LESSONS FROM CLINICAL CASE (2022) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Heart failure therapy: the fifth card (2023) (0)
- 87Effects of the chymase inhibitor fulacimstat on adverse cardiac remodelling after acute myocardial infarction - Results of the CHIARA MIA 2 trial (2019) (0)
- Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure (2022) (0)
- [Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice]. (2022) (0)
- P226 LONGITUDINAL EVALUATION OF CONGESTION AND RENAL FUNCTION IN ADVANCED HEART FAILURE PATIENTS TREATED WITH A LEFT VENTRICULAR ASSIST DEVICE (2022) (0)
- ROLE OF EXERCISE STRESS ECHOCARDIOGRAPHY IN PREDICTING LONG-TERM HEMODYNAMIC AND FUNCTIONAL OUTCOME IN PATIENTS UNDERGOING SURGERY FOR CHRONIC ISCHAEMIC MITRAL VALVE REGURGITATION (2020) (0)
- Evidence of superiority of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers in the heart failure with reduced ejection fraction patient's journey (2021) (0)
- QRS FRAGMENTATION: VALIDATION OF A NEW EKG DIAGNOSTIC AND PROGNOSTIC MARKER IN ACUTE MYOCARDITIS (2020) (0)
- P595 Anti-TNF alfa therapy in patients with inflammatory bowel disease and coronary syndrome: efficacy and safety (2013) (0)
- Health Status Across Major Subgroup of Patients with Heart Failure and Preserved Ejection Fraction. (2023) (0)
- Barore flex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction (2015) (0)
- Ventricular arrhythmias among patients with implantable cardioverter defibrillator during the COVID-19 epidemic: Insights from the Italian frontline (2020) (0)
- Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial (2021) (0)
- How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion. (2023) (0)
- [Role of the right ventricle in heart failure with preserved ejection fraction]. (2019) (0)
- ASPIRIN DESENSITIZATION IN PATIENTS WITH ACETYLSALICYLIC ACID SENSITIVITY: LONG TERM OUTCOME (2014) (0)
- QRS FRAGMENTATION: A POSSIBLE NEW MARKER OF EDEMA AND FIBROSIS IN MYOCARDITIS (2019) (0)
- Abstract 15321: Impact of Exercise Right Ventricular Performance on Functional Capacity in Patients Undergoing Mitral Valve Surgery for Chronic Ischemic Mitral Regurgitation: A Longitudinal Study (2017) (0)
- 345 The Cardiovascular Medicine‐HF index is useful in estimating the use of resources in heart failure elderly patients (2008) (0)
- Abstract 17063: Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure (2020) (0)
- Clinical features, and in-hospital and 1-year mortalities of patients with acute heart failure and severe renal dysfunction. Data from the (2013) (0)
- RIGHT HEART ADAPTATION TO EXERCISE IN PULMONARY HYPERTENSION: AN INVASIVE HEMODYNAMIC STUDY (2023) (0)
- Congestive Heart Failure in the Community: Changes in Incidence and Survival Over a 10-Year Period (1998) (0)
- Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study (2022) (0)
- 275 Role of right ventricle in acute heart failure with preserved ejection fraction: a comparison between hypertensive pulmonary edema and decompensated heart failure (2020) (0)
- cardiomyopathy: The relevance of the left ventricular equator as a prognostic Surgical ventricular reverse remodeling in severe ischemic dilated (2013) (0)
- 728 Force-frequency relationship during dobutamine stress echo: noninvasive exercise-independent assessment of left ventricular contractility (2003) (0)
- In pursuit of balance: renin–angiotensin–aldosterone system inhibitors and hyperkalaemia treatment (2023) (0)
- [The spiral of evil: iatrogenic coronary and aortic dissection]. (2017) (0)
- Abstract 20606: Persistent Low Oxygen Saturation During Sleep Predicts Impaired Pulmonary Vascular Response to Exercise in Patients With Sleep Disordered Breathing (2016) (0)
- Abstract 12208: Mode of Death in Heart Failure With Preserved Ejection Fraction: A Systematic Review (2016) (0)
- 106 Feasibility and burden of multidimensional assessement of heart failure elderly in clinical practice: data from the IMAGE-HF Study (2008) (0)
- SAT0206 Role of Tissue Doppler Echocardiography in Detecting Preclinical Cardiac Involvement in Systemic Sclerosis Patients (2013) (0)
- Peculiar hemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization (2020) (0)
- Abstract 16721: Mechanical versus Biological Prostheses for Chronic Ischaemic Mitral Regurgitation: A Long-Term Hemodynamic and Functional Capacity Comparison (2014) (0)
- How should I treat a challenging case of MitraClip implantation? (2014) (0)
- Interleukin-1β receptor antagonist and pericardial constriction (2015) (0)
- P773Initiation of sacubitril/valsartan and optimisation of evidence-based heart failure therapies after hospitalisation for acute decompensated heart failure: An analysis of the TRANSITION study (2019) (0)
- Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 1 (2016) (0)
- Four aces of heart failure therapy: systematic review of established and emerging therapies for heart failure with reduced ejection fraction (2022) (0)
- N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE VERSUS CLINICAL RISK SCORES FOR PROGNOSTIC STRATIFICATION IN HEART FAILURE PATIENTS (2018) (0)
- Right heart adaptation during exercise in pulmonary arterial hypertension and in pulmonary hypertension due to heart failure with preserved ejection fraction (2022) (0)
- [Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure]. (2001) (0)
- TAVI in moderate aortic stenosis and heart failure: pros and cons. (2022) (0)
- Telemedicine and Teleconsulting in the Era of COVID-19 Pandemic: A Useful Tool from Screening to Intensive Care Monitoring (2021) (0)
- 692 A novel prognostic index including comorbidities for stable heart failure validated in different clinical settings (2006) (0)
- Target Dose of Sacubritil/Varsartan Achieved in Most Patients with HFrEF Irrespective of Baseline SBP (2016) (0)
- Abstract 18060: Risk Stratification Following Mitral Valve Surgery for Chronic Ischemic Mitral Regurgitation: A Very Long-term Study (2015) (0)
- Exercise-induced changes in pulmonary artery wedge pressure: insights from heart failure with preserved ejection fraction (2020) (0)
- Skeletal Muscle-powered Circulatory Assistance: Muscle Conditioning (1990) (0)
- Psychosocial, cognitive and functional characterization of patients with advanced heart failure (0)
- ASYMPTOMATIC LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN A HIGH-RISK POPULATION ENROLLED IN A PRIMARY CARE SETTING: PREVALENCE AND SCREENING VALUE OF ELECTROCARDIOGRAPHY AND NATRIURETIC PEPTIDES: THE DAVID-BERG STUDY (2011) (0)
- Bridging therapy with low molecular weight heparin in patients with coronary stents undergoing surgery (2013) (0)
- 388 Haemodynamic arterial changes in heart failure: a proposed new paradigm of heart and vessels failure. The Copernican revolution? (2021) (0)
- 2060Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study (2017) (0)
- [Emergency surgery of acute coronary insufficiency]. (1992) (0)
- Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction. (2021) (0)
- 1075 Force frequency relationship during dobutamine stress echo predicts response to medical therapy in heart failure patients (2005) (0)
- 89 Cardiac resynchronization in combination with Betablocker treatment in advanced Heart Failure (CARIBE-HF): the results of the CARIBE study (2006) (0)
- P595Risk scores or NT-proBNP for prognostic stratification of heart failure patients? (2017) (0)
- Abstract 12790: Classification of the Different Types of Hypertrophic Cardiomyopathy Responsible for Advanced Heart Failure: From Clinical, Morphofunctional Characteristics to Prognosis and Potential New Therapies (2020) (0)
- [Cardiovascular medicine unit: preliminary results of an in-hospital multidisciplinary intervention in heart failure]. (2006) (0)
- ramp test to detect pump malfunction in the HVAD. (0)
- [The MITRA-FR and COAPT trials: the clinical cardiologist's point of view]. (2019) (0)
- [Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy]. (2015) (0)
- P.02.19 ANTI-TNFALPHA THERAPY IN PATIENTS WITH CORONARY SYNDROME AND INFLAMMATORY BOWEL DISEASE: EFFICACY AND SAFETY (2013) (0)
- Images in cardiology Microvascular ischaemia after cardiac arrest in a patient with hypertrophic cardiomyopathy (2015) (0)
- Microvascular ischaemia after cardiac arrest in a patient with hypertrophic cardiomyopathy (2015) (0)
- CORONARY ARTERY DISEASE Original Studies A Multidisciplinary Consensus Document on Follow-Up Strategies for Patients Treated With Percutaneous Coronary Intervention (2015) (0)
- P1637Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study (2019) (0)
- Persistence of Late Gadolinium Enhancement in Post-Acute Myocarditis Imaging (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michele Senni?
Michele Senni is affiliated with the following schools:
